From the Food and Drug Administration.
Schwetz
B A
BA
Food and Drug Administration.
D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation*; D003920:Diabetes Mellitus / Q000097:blood*; D004348:Drug Labeling; D015738:Famotidine / Q000008:administration & dosage*; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000897:Anti-Ulcer Agents; D001786:Blood Glucose; D009883:Ophthalmic Solutions; D015738:Famotidine